You are here

RSVpreF

Pfizer's maternal RSV vaccine filing gets priority review, setting up showdown with AstraZeneca, Sanofi

Fierce Pharma

Tue, 02/21/23 - 10:26 am

Pfizer's RSV vaccine rush gets FDA boost with priority review

Fierce Biotech

Wed, 12/7/22 - 11:45 pm

priority review

Pfizer heads to the FDA with an early lead over rivals in the $10B RSV vaccine market

Endpoints

Thu, 08/25/22 - 11:27 am

RSVVW 2021 – Pfizer gets maternal

EP Vantage

Mon, 11/1/21 - 11:01 pm

Could This Be Pfizer's Next Blockbuster Vaccine?

Motley Fool

Fri, 09/10/21 - 11:00 am

clinical trials